These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8388791)

  • 1. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.
    Malanoski GJ; Eliopoulos GM; Ferraro MJ; Moellering RC
    Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):131-3. PubMed ID: 8388791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
    Gorzynski EA; Gutman SI; Allen W
    Antimicrob Agents Chemother; 1989 Apr; 33(4):591-2. PubMed ID: 2524998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
    Ikerd TR; Koletar SL
    J Antimicrob Chemother; 1993 Apr; 31(4):615-7. PubMed ID: 8390436
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
    Sugita K; Katouno Y; Uchida H; Kobayashi Y
    Jpn J Antibiot; 2002 Dec; 55(6):771-7. PubMed ID: 12621731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi.
    Preac-Mursic V; Wilske B; Schierz G; Süss E; Gross B
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):651-3. PubMed ID: 2550233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H; Bébéar C
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
    Perronne C; Gikas A; Truffot-Pernot C; Grosset J; Vilde JL; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1356-9. PubMed ID: 1656860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of new investigational agents against Helicobacter pylori.
    Osato MS; Reddy SG; Piergies AA; Bochenek WJ; Testa RT; Graham DY
    Aliment Pharmacol Ther; 2001 Apr; 15(4):487-92. PubMed ID: 11284777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
    Waites KB; Cassell GH; Canupp KC; Fernandes PB
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates.
    Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1996 Feb; 24(2):113-6. PubMed ID: 9147907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
    Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
    Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan.
    Cheng A; Sheng WH; Liou JM; Wang HP; Wu MS; Lin JT; Chang SC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):72-9. PubMed ID: 23036269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents.
    Debets-Ossenkopp YJ; Namavar F; MacLaren DM
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):353-5. PubMed ID: 7649202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori.
    Grignon B; Tankovic J; Mégraud F; Glupczynski Y; Husson MO; Conroy MC; Emond JP; Loulergue J; Raymond J; Fauchère JL
    Microb Drug Resist; 2002; 8(1):61-6. PubMed ID: 12002651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years.
    Boyanova L; Spassova Z; Krastev Z; Petrov S; Stancheva I; Docheva J; Mitov I; Koumanova R
    Diagn Microbiol Infect Dis; 1999 Aug; 34(4):309-13. PubMed ID: 10459482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of quinolone-resistant Campylobacter jejuni to new macrolide antibiotics.
    Endtz HP; Broeren M; Mouton RP
    Eur J Clin Microbiol Infect Dis; 1993 Jan; 12(1):48-50. PubMed ID: 8462563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
    Van Asselt GJ; Sloos JH; Mouton RP; Van Boven CP; Van de Klundert JA
    J Med Microbiol; 1995 Nov; 43(5):386-91. PubMed ID: 7563004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella.
    Martin SJ; Pendland SL; Chen C; Schreckenberger P; Danziger LH
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1419-21. PubMed ID: 8726012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.
    Nilius AM; Bui MH; Almer L; Hensey-Rudloff D; Beyer J; Ma Z; Or YS; Flamm RK
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2163-8. PubMed ID: 11408246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods.
    Mehaffey PC; Putnam SD; Barrett MS; Jones RN
    J Clin Microbiol; 1996 Feb; 34(2):479-81. PubMed ID: 8789046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.